In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sequana Medical NV

http://www.sequanamedical.com/

Latest From Sequana Medical NV

European Investor LSP Raises $600M For Life Sciences Fund

LSP says its new fund for medical device and drug development companies will be the biggest fund dedicated to life sciences companies in Europe.

Europe Financing

Sequana Medical Secures $21M In Private Placement

One year on from its IPO on Euronext Brussels, abdominal implant maker Sequana Medical has secured €19m ($21m) in an equity placement. The company said it had been backed by new and existing investors. 

Clinical Trials Financing

Sequana Encouraged By First-In-Human Single Dose DSR study

Sequana Medical has reported results from the first-in-human single-dose direct sodium removal (DSR) proof-of-concept study for volume overload due to heart failure.

Cardiovascular Clinical Trials

Sequana Medical Launches Belgian IPO

Sequana Medical has launched an IPO on Euronext Brussels a few days after the US FDA granted a breakthrough device designation to Sequana’s alfapump for liver ascites. 

Financing Belgium
See All

Company Information

  • Industry
  • Medical Devices
UsernamePublicRestriction

Register